SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway

Title
SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 714, Issue 1-3, Pages 23-31
Publisher
Elsevier BV
Online
2013-06-11
DOI
10.1016/j.ejphar.2013.05.043

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started